Tales from the Heart

The Generic Drug Wake-Up Call

Lisa Salberg sits down with whistleblower Dinesh Thaker to examine the hidden risks within the generic drug supply chain and why stronger oversight is urgently needed. Together, they discuss drug quality, patient safety, and how advocacy can help drive meaningful change in the healthcare system.

 

This conversation was recorded June 17, 2026.

Summer Strategies for Living Well

Lisa Salberg and Dr. Steve Ommen discuss practical ways to stay healthy with HCM during the busy summer months. They also break down promising new drug research, explain what emerging biomarkers mean for patients, and share why planning ahead can help people with HCM enjoy life with greater confidence.

 

This conversation was recorded June 19, 2026.

Surgery, Science and HCM Success

Lisa Salberg sits down with Dr. Nicholas Smedira of the Cleveland Clinic to explore how HCM surgery has evolved over the past three decades. They discuss myectomy, myosin inhibitors, surgical innovation, patient selection, and why experience and high-volume centers continue to matter in achieving the best outcomes for patients.

 

This conversation was recorded June 8, 2026.

Building HCM Care in Alaska

Lisa Salberg welcomes Dr. Ahmed "Sami" Abuzaid to discuss the growth of specialized HCM care in Alaska. They explore building a regional HCM program, expanding access to clinical trials, improving health equity, and what patients need to know about navigating care in remote communities.

 

This conversation was recorded June 5, 2026.

MRI Insights and HCM Risk

Lisa Salberg welcomes Dr. Christopher Kramer to discuss groundbreaking findings from the international HCMR Registry. They explore how cardiac MRI, scar burden, heart muscle mass, and biomarkers may improve risk prediction and help shape the future of personalized HCM care.

 

This conversation was recorded on May 29, 2026

HCM Breakthroughs and Tough Questions

Lisa Salberg and Dr. Alex de Feria explore the latest developments in HCM care, from promising non-obstructive HCM therapies to the challenges of recognizing symptoms, managing medications, and assessing sudden cardiac death risk. They also discuss clinical trials, fibrosis research, and why the future of HCM treatment has never looked brighter.

 

This conversation was recorded May 28, 2026.

Expanding Access to HCM Expertise

Host Lisa Salberg talks with Dr. Ronald H. Wharton about building a nationally recognized HCM Center of Excellence at Northwell Health on Long Island. They discuss patient education, new myosin inhibitor therapies, clinical trials, and why specialized HCM care can change lives for patients and families.

 

This conversation was recorded 5/21/26

The Pulse Behind HCM

Lisa Salberg welcomes Steven Kelley and Matt Grant to discuss HCMA’s new discussion group for men 40-ish and under living with HCM. The conversation explores friendship, mental health, dating, devices, and building a supportive space where younger men can openly share their experiences and connect with others facing similar challenges.

 

This conversation was recorded May 15, 2026.

The Future of HCM Care

Lisa Salberg and Dr. Michael Ayers explore the rapidly evolving world of HCM treatment, from myosin inhibitors and clinical trials to AFib management and patient-centered care. The episode also dives into advocacy, drug safety concerns, and why personalized treatment strategies matter more than ever for people living with hypertrophic cardiomyopathy.

This conversation was recorded May 15, 2026.

New Directions in HCM Treatment

Lisa Salberg and Dr. Marty Maron break down the rapidly changing landscape of HCM treatment, including the growing role of myosin inhibitors and what new clinical trial data could mean for patients. The conversation also explores beta blockers, shared care models, Centers of Excellence, and why personalized treatment matters more than ever.

 

This conversation was recorded May 8, 2026.